Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • beetle_doc
    Member
    • Dec 2007
    • 13

    Keeping business from going elsewhere

    Don't know if this is the right forum for this question. We have lost a substantial amount of our on campus illumina sequencing business to other service providers (mostly BGI) over the last year. I have talked to some of our researchers and this is almost exclusively due to our rates being too high. We are still running a HiSeq 2500 with v3 chemistry as our instrument was too old to upgrade to the v4 chemistry. We are thinking about getting a HiSeq 4000 to hopefully allow us to reduce our rates. However, I am not sure if or when this will happen.

    I took a look online and our prices are similar to what other core facilities are charging. My questions are: Have other core facilities seen a drop in their business and what steps are you taking to keep your on campus customer base?
    Thanks
  • ymc
    Senior Member
    • Mar 2010
    • 496

    #2
    I think BGI and Illumina are not in good terms now. So if you can get a 4000, it certainly helps.

    But how could you lose your on campus customers? Aren't they supposed to get lower rate than outsiders? If your internal rate is similar to other people's outsider rate, then it is no surprise that you are losing customers.

    Comment

    • sarvidsson
      Senior Member
      • Jan 2015
      • 137

      #3
      Offer high quality, customized services with good support. It is difficult to win on price for bulk sequencing alone.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...